The potential bufering role of self‑efcacy and pain acceptance against invalidation in rheumatic diseases by Cameron,  Nigel  et al.
Vol.:(0123456789) 
Rheumatol Int (2018) 38:283–291 
https://doi.org/10.1007/s00296-017-3859-2
PATIENT OPINION
The potential buffering role of self‑efficacy and pain acceptance 
against invalidation in rheumatic diseases
Nigel Cameron1  · Marianne Kool2 · Fernando Estévez‑López1,3  · 
Isabel López‑Chicheri4  · Rinie Geenen1  
Received: 23 May 2017 / Accepted: 19 October 2017 / Published online: 30 October 2017 
© The Author(s) 2017. This article is an open access publication
associated with lack of understanding. The combined 
occurrence of high self-efficacy and high acceptance was 
associated most clearly with lower lack of understanding 
(interaction: t = − 2.12, p = 0.034). The findings suggest 
the usefulness of examining whether interventions aimed at 
increasing self-efficacy and pain acceptance can help people 
with rheumatic diseases for whom invalidation is a consider-
able burden.
Keywords Acceptance · Acceptance and commitment 
therapy · Invalidation · Psychological adjustment · 
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Introduction
Invalidation is a common experience in people with a 
rheumatic disease. It includes non-acceptance by others, 
misunderstanding, disbelief, rejection, stigmatization, and 
suspicion that the problem is exaggerated or psychologi-
cal [1]. Two major dimensions of invalidation have been 
identified: lack of understanding and discounting [2]. Lack 
of understanding reflects a lack of positive responses such 
as not recognizing, not comprehending, and not emotion-
ally supporting the person. Discounting represents negative 
social responses and social rejection, including disbelieving, 
admonishing, dismissing inability to work, not acknowledg-
ing symptom fluctuations, and offering unusable advice. In 
rheumatic diseases, invalidation is related to worse physi-
cal and mental health [3, 4]. Pain and fatigue, which are 
the main symptoms in rheumatic diseases, are mostly not 
observable [5]. Therefore, symptoms and the consequent 
burden in people with rheumatic diseases are often poorly 
acknowledged and understood by others.
Abstract A substantial amount of people with a rheu-
matic disease perceive invalidation consisting of lack of 
understanding and discounting (negative social responses). 
To get insight into the potential buffering role of self-effi-
cacy and pain acceptance against invalidation, this cross-
sectional study examined associations between these vari-
ables. Spanish speaking people (N = 1153, 91% female, 
mean age 45 ± 11 years) with one or multiple rheumatic 
diseases completed online the Illness Invalidation Inven-
tory, the Chronic Pain Acceptance Questionnaire, and the 
Chronic Disease Self-Efficacy Scale. Higher self-efficacy 
(t = − 4.80, p = < 0.001) and pain acceptance (t = − 7.99, 
p = < 0.001) were additively associated with discounting. 
Higher self-efficacy (t = − 5.41, p = < 0.001) and pain 
acceptance (t = − 5.71, p = < 0.001) were also additively 
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Invalidation depends on both the response of others to a 
person (objective invalidation) and on the appraisal that the 
person makes of such a response (subjective invalidation). 
To reduce objective invalidation, people near the patient 
should not deny the existence of what cannot be observed 
and they should not lecture, patronize, or overprotect the 
person. Instead they should listen, try to understand, and 
acknowledge the disorder and the person, and help (instru-
mental), comprehend and emotionally support the person. 
However, severity of invalidation not only depends on the 
actual invalidation by the social environment but also on the 
perception and skills of the person. This article focuses on 
subjective evaluation of invalidation and on skills that may 
help people to experience less invalidation.
To support people in dealing with adversities in life, 
management options are commonly derived from two broad 
treatment modalities: classical cognitive behavioral therapy 
(CBT) and acceptance and commitment therapy (ACT). 
CBT aims at increasing coping skills by promoting helpful 
thoughts and behavior [6]. ACT aims at accepting difficulties 
and to be committed to make changes in daily life that are in 
agreement with one’s life values [7]. Among the individual 
differences that may influence the experience of invalida-
tion, self-efficacy [8] and acceptance [9, 10] skills are more 
or less prototypical for these CBT and ACT modalities, 
respectively. In the current study, self-efficacy and accept-
ance are operationalized as chronic disease self-efficacy and 
pain acceptance.
Self-efficacy is the personal belief that one can suc-
cessfully perform particular behaviors to achieve a goal 
[11], such as managing pain [8] or managing daily chal-
lenges [12] and the consequences of a rheumatic disease 
[13–15]. Chronic disease self-efficacy has been related to 
less health distress, illness intrusiveness, activity limitation, 
depression and fatigue [as summarized in 16]. In analogy 
to these observed correlations, it is our hypothesis that self-
efficacy to deal with a chronic disease is also related to less 
invalidation.
Pain acceptance, entails an active willingness to engage in 
meaningful activities in life despite having pain, and a reduc-
tion of unsuccessful attempts to avoid or control pain [17]. 
Greater pain acceptance has been related to less attention 
to pain [18], lower levels of pain-related anxiety and avoid-
ance, less depression, and less physical and psychosocial 
disability [19–21]. Acceptance was also indicated to buffer 
the effect of negative affect on pain levels [9]. We chose pain 
acceptance as a measure of acceptance, because for any per-
son with fibromyalgia, chronic pain is a primary symptom 
one needs to deal with, and a questionnaire to measure pain 
acceptance is available [22]. People who are able to accept 
their pain are assumed to be less in need of validation by 
others. Therefore, we hypothesize that people who accept 
their pain more are less likely to experience invalidating 
responses by others.
People who have a flexible repertoire of abilities are 
assumed to best deal with different kinds of unsatisfac-
tory situations [23]. High coping skills such as reflected in 
chronic disease self-efficacy will make people feel compe-
tent to deal with situations in which control of invalidation 
is possible, while high acceptance skills will help people 
to actively and in full awareness experience even adverse 
situations without unnecessary attempts to change their fre-
quency or form [7], which is a desirable skill when situations 
are hard to control.
Therefore, the aim of the present study was to exam-
ine the association of self-efficacy and pain acceptance 
with invalidation in people with a rheumatic disease. We 
hypothesized that high chronic disease self-efficacy and high 
pain acceptance are additively associated with low invalida-
tion. Moreover, we hypothesized that people with both high 
chronic disease self-efficacy and high pain acceptance will 
experience a particularly low level of invalidation, which 
will be shown in a significant prediction of invalidation 
from the interaction between chronic disease self-efficacy 
and pain acceptance. Our cross-sectional design only allows 
correlational analyses and interpretations. We do not have 
the intention of establishing or implying causality. How-
ever, if the present study shows that self-efficacy and pain 
acceptance are associated with less invalidation, this will 
stimulate the design of prospective studies and therapies to 
test whether these factors help in dealing with invalidation.
Methods
Participants and procedure
The study was conducted according to the principles of the 
Declaration of Helsinki [24] and approved by the medi-
cal ethical review board of the University Medical Center 
Utrecht (Utrecht, The Netherlands). The study is part of an 
international online research project on invalidation in rheu-
matic diseases [25]. Participants were invited to take part 
in an online survey via a recruitment notice on websites of 
patient associations for rheumatic diseases located in vari-
ous nations. The recruitment notice included information 
about the aim and content of the study, inclusion criteria, 
duration of participation (about 20 min), confidentiality, and 
a hyperlink to the online questionnaire. Participants could 
decide to participate after being informed about the study 
and were able to stop at any point if they desired to do so.
Each language version of the online research project 
had different questionnaires included next to the standard 
questionnaire package. The Spanish version included the 
questionnaire ‘Chronic Pain Acceptance Questionnaire 
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(CPAQ)’ and ‘Spanish Chronic Disease Self-Efficacy Scale 
(SEMCD-S)’ to be able to study these concepts in relation 
to invalidation.
Inclusion criteria were (1) to report being diagnosed 
of at least one rheumatic disease by a health professional, 
(2) to be at least 18 years old, and (3) to have invalidation 
(discounting and lack of understanding) scores from at 
least three out of five sources of invalidation. This was 
done because calculating a mean invalidation score for 
one or two sources would have been less reliable [4]. Of 
the initial 1623 people of Spanish speaking countries who 
started with the online questionnaire, 1153 participants 
(71%) were included. The 470 participants were excluded 
for the following reasons: for 199 participants it was 
unknown whether the rheumatic disease was diagnosed 
by a health professional, 20 participants were younger 
than 18 years, 85 participants did not fill out the invali-
dation questionnaire, 136 participants had filled out less 
than three sources of the invalidation questionnaire, and 
30 participants had submitted the questionnaires two or 
more times as was shown by a similar e-mail address, IP 
address, and year of birth.
Demographic and health-related characteristics of 
the sample are shown in Table  1. Most participants 
were female (91%) and with an average age of 45.4 
(range = 18–82) years. Our dataset included the total years 
of received education since the age of 4. Education levels 
were estimated using the number of years it commonly 
takes to pass each level of the Spanish education system: 
primary level 1–8 years, secondary level 9–14 years, and 
tertiary level > 14 years.
Instruments
The Illness Invalidation Inventory [3*I; 2] was used to 
measure the degree of invalidation on the two domains 
‘Discounting’ and ‘Lack of Understanding’ using the same 
eight items to refer to five potential sources of invalidation: 
Spouse, Family, Medical professionals, Work, and Social 
services. An example item is ‘My family thinks I should 
be tougher’. The items of the 3*I are answered on a 5-point 
Likert scale ranging from ‘Never’ (1) to ‘Very often’ (5). 
A high score means a high level of invalidation. The inter-
nal consistency of the 3*I can be classified as good [2, 26]. 
In the current study, the internal consistency was high for 
the sources of lack of understanding (three items, Spouse; 
α = 0.85, Family; α = 0.85, Medical professionals; α = 0.86, 
Work; α = 0.78, Social services; α = 0.86) and discounting 
(five items, Spouse; α = 0.75, Family; α = 0.81, Medical 
professionals; α = 0.82, Work; α = 0.85, Social services; 
α = 0.88). If a particular source of invalidation did not apply 
to them during the past year (e.g., because they did not have 
a spouse or work), then the patient was instructed to skip 
that part of the questionnaire. Mean scores for lack of under-
standing and discounting were calculated across the (at least 
three) available sources of invalidation [4].
The SEMCD-S [16, 27] measures self-efficacy in people 
with a chronic disease. The Spanish version consists of four 
items instead of the original six items, because the internal 
consistency was higher when excluding two items with the 
lowest item-to-scale correlations [28]. An example of an 
item is: ‘How confident are you that you can keep the fatigue 
caused by your disease from interfering with the things you 
want to do?’ Items are rated on an 11-point Likert scale 
ranging from 0 (never true) to 10 (always true). A high score 
reflects a higher level of self-efficacy. Reliability and valid-
ity of SEMCD-S were indicated to be good [16]. Internal 
consistency in the current study was very good (α = 0.91).
The brief 20-item version of the CPAQ [22] was used to 
measure pain acceptance. The questionnaire includes two 
dimensions: The Activity Engagement subscale (11 items) 
measures participation in daily activities while acknowledg-
ing the presence of pain, and the Pain Willingness subscale 
(9 items) that measures the degree to which pain is allowed 
in experience without efforts to avoid or control it. In the 
current study, to prevent that the model is obstructed by 
shared variance of two correlated predictor variables and 
to be able to compare one score that is characteristic for 
pain acceptance with one self-efficacy score, we used the 
Table 1  Characteristics of participants (N = 1153)
SD standard deviation, SEMCD-S Spanish Chronic Disease Self-effi-
cacy Scale, CPAQ Chronic Pain Acceptance Questionnaire, 3*I Ill-
ness Invalidation Inventory
Gender: female, n (%) 1045 (90.6)
Gender: male, n (%) 108 (9.4)
Age, mean (SD) years 45.4 (10.5)
Education level, n (%)
 Primary, 1–8 years education after 4 years of age 7 (0.6)
 Secondary, 9–14 years education after 4 years of age 377 (32.7)
 Tertiary, > 14 years education after 4 years of age 769 (66.7)
Invalidation (3*I), mean (SD)
 Discounting 2.64 (0.82)
 Lack of understanding 2.60 (0.81)
Self-efficacy (SEMCD-S), mean (SD) 4.78 (2.23)
Pain acceptance (CPAQ), mean (SD) 2.84 (0.83)
Rheumatic disease, n (%)
 Fibromyalgia 388 (33.7)
 Rheumatoid arthritis 111 (9.6)
 Ankylosing spondylitis 63 (5.5)
 Systemic lupus erythematosus 124 (10.8)
 Sjögren’s syndrome 35 (3.0)
 A single other rheumatic disease 69 (6.0)
 Fibromyalgia and another rheumatic disease 258 (22.4)
 Multiple rheumatic diseases; not fibromyalgia 105 (9.1)
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total score for pain acceptance, i.e., the sum of the scores 
at both dimensions. Example items are: ‘My life is going 
well, even though I have chronic pain’ and ‘I need to con-
centrate on getting rid of my pain’ (reversed sign). The items 
are rated on a 7-point Likert scale from 0 (never true) to 
6 (always true). A high score means a high acceptance of 
pain. Reliability and validity of the CPAQ subscales have 
been indicated to be good [22]. Internal consistency of the 
total score for pain acceptance in the current study was good 
(α = 0.79).
Cutoff values for invalidation, self‑efficacy, and pain 
acceptance
To describe participants’ levels of invalidation, self-efficacy, 
and pain acceptance as either ‘high’ or ‘low’, cutoff val-
ues were set by the authors at the middle of the response 
scales: 3.0 for discounting and lack of understanding (invali-
dation), 5.5 for self-efficacy, and 3.0 for pain acceptance. 
Lower scores on the two dimensions of invalidation and 
higher scores on self-efficacy and pain acceptance are more 
favorable.
Statistical analyses
Statistical analyses were done with the Statistical Package 
for Social Sciences (SPSS version 21.0). Significance lev-
els were set at p < 0.05 (two-tailed). The residual plots in 
regression analyses showed that the assumptions of linearity 
and normality were met (data not shown).
To test our hypotheses that self-efficacy, pain accept-
ance, and the interaction of self-efficacy and pain acceptance 
are associated with low invalidation, multiple hierarchical 
regression analyses were performed for discounting and lack 
of understanding separately. In Block 1, the demographic 
variables age, education level and gender were entered. 
Centered scores of self-efficacy and pain acceptance were 
entered in Block 2. In Block 3, the self-efficacy × pain 
acceptance interaction was entered, and in Block 4, fibro-
myalgia was entered to check whether results were not due 
to having a fibromyalgia diagnosis, because invalidation is 
experienced more often by people with fibromyalgia than by 
people with other rheumatic diseases [2].
Results
Percentage deviating scores
Figure 1 depicts percentages of people with low self-effi-
cacy, low pain acceptance, high discounting, and high lack 
of understanding per specific rheumatic disease.
Hierarchical regression analyses
Table 2 shows the results of the hierarchical regression 
analyses examining whether both dimensions of invalida-
tion separately (discounting and lack of understanding) were 
associated with gender, age, education, self-efficacy, pain 
acceptance, the interaction of self-efficacy and pain accept-
ance, and fibromyalgia. The regression model for discount-
ing showed that, in Block 1, gender and education were not 
associated with discounting while a higher age was associ-
ated with lower discounting (t = − 2.03, p = 0.042). In Block 
2, higher levels of self-efficacy (t = − 4.80, p = < 0.001) and 
pain acceptance (t = − 7.99, p = < 0.001) were both addi-
tively associated with lower levels of discounting. One unit 
increase on self-efficacy and pain acceptance were associ-
ated with 0.06 and 0.25 units decrease on discounting. In 
Block 3, the interaction of self-efficacy and pain acceptance 
had no significant association with discounting (t = − 1.79, 
p = 0.072). In Block 4, although fibromyalgia was associated 
with more discounting (t = 6.39, p = < 0.001), the rela-
tion of discounting with self-efficacy and pain acceptance 
remained intact after inclusion of the fibromyalgia diagnosis 
in the model.
The regression model for lack of understanding showed 
that, in Block 1, neither gender nor age or education were 
associated with lack of understanding. In Block 2, higher 
levels of self-efficacy (t = − 5.41, p = < 0.001) and pain 
acceptance (t = − 5.71, p = < 0.001) were additively associ-
ated with lack of understanding. One unit increase on self-
efficacy and pain acceptance were associated with 0.07 and 
0.18 units decrease on lack of understanding. In Block 3, the 
interaction of self-efficacy and pain acceptance was associ-
ated with lack of understanding (t = − 2.12, p = 0.034). 
Figure 2 displays the interaction effect. The graph shows that 
particularly people who had both high self-efficacy and high 
pain acceptance perceived the least lack of understanding. In 
Block 4, although fibromyalgia was associated with higher 
lack of understanding (t = 6.55, p = < 0.001), the relation of 
discounting with self-efficacy and pain acceptance remained 
intact after the inclusion of fibromyalgia diagnosis in the 
model.
Discussion
To establish whether both self-efficacy and pain acceptance 
may buffer against invalidation, our study examined the rela-
tionship of the two factors with invalidation. Our findings 
confirm that the level of invalidation is lower among people 
with rheumatic diseases with a higher level of either self-
efficacy or pain acceptance. Moreover, people with both high 
self-efficacy and high pain acceptance showed even lower 
invalidation: the combination of high self-efficacy and high 
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Fig. 1  Percentages of participants with low self-efficacy, low pain acceptance, high discounting, and high lack of understanding per rheumatic 
disease; *p < 0.05, ** p < 0.01, *** p < 0.001
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pain acceptance was significantly associated with low lack 
of understanding. This interaction was not significant for 
discounting.
Since the seminal work of Bandura [11] on self-efficacy, 
it has been shown that self-efficacy helps in dealing with 
numerous adversities [8, 12, 29] and that self-efficacy is an 
important component of self-management in chronic dis-
eases [30] including rheumatic diseases [31]. Our correla-
tional observation does not allow causal interpretations. The 
association may reflect that confidence to effectively deal 
with the disease and its consequences includes competency 
to deal with invalidation but it may also reflect that receiving 
less invalidation is positive for one’s confidence to deal with 
disease. In previous research, self-efficacy has been shown 
to be associated with self-management and the outcome 
of self-management programs [32, 33]. Moreover, a self-
management program was shown to increase self-efficacy 
to manage pain [34]. This suggests that it is worth trying to 
reduce invalidation by increasing self-efficacy skills to deal 
with the disease and invalidation, which should be evaluated 
in future research.
Having taken account of chronic disease self-efficacy, our 
study showed that pain acceptance was additively associated 
with invalidation. Likely the higher scores on acceptance of 
pain reflect a general flexible willingness of people to have 
undesirable experiences without attempting to control them 
[35]. While the restructuring of cognitions and behavior is a 
fruitful approach to help people to deal with situations that 
Table 2  Hierarchical 
regression analyses predicting 
the two dimensions of 
invalidation, discounting and 
lack of understanding, from 
demographic variables, self-
efficacy, pain acceptance, and 
fibromyalgia in 1153 people 
with rheumatic diseases
Education level, number of years education after 4  years of age: primary 1–8  years (low), secondary 
9–14 years (middle), tertiary > 14 years (high)
SEMCD-S Spanish Chronic Disease Self-efficacy Scale, CPAQ Chronic Pain Acceptance Questionnaire, 
3*I Illness Invalidation Inventory
*p < 0.05, **p < 0.01, ***p < 0.001
Variable Discounting (3*I) Lack of understanding (3*I)
b β Adj. R2 b β Adj. R2
Block 1 0.001 0.003
 Gender 0.050 0.083 − 0.138 − 0.049
 Age − 0.005* 0.002 0.004 0.055
 Education (low) 0.181 0.312 0.178 0.017
 Education (high) 0.036 0.052 0.061 0.035
Block 2 0.131*** 0.102***
 Gender 0.020 0.077 − 0.156* − 0.056
 Age − 0.004 0.002 0.005* 0.067
 Education (low) 0.102 0.291 0.097 0.009
 Education (high) 0.100* 0.048 0.118* 0.069
 Self-efficacy (SEMCD-S) − 0.057*** 0.012 − 0.065*** − 0.178
 Pain acceptance (CPAQ) − 0.254*** 0.032 − 0.183*** − 0.187
Block 3 0.132*** 0.104*
 Gender 0.018 0.077 − 0.159* − 0.057
 Age − 0.004 0.002 0.005* 0.067
 Education (low) 0.108 0.291 0.104 0.010
 Education (high) 0.099* 0.048 0.117* 0.068
 Self-efficacy (SEMCD-S) − 0.056*** 0.012 − 0.064*** − 0.174
 Pain acceptance (CPAQ) − 0.253*** 0.032 − 0.182*** − 0.186
 Self-efficacy × pain acceptance − 0.020 0.011 − 0.024* − 0.060
Block 4 0.162*** 0.136***
 Gender 0.092 0.077 − 0.082 − 0.029
 Age − 0.008*** 0.002 0.002 0.021
 Education (low) 0.094 0.286 0.089 0.009
 Education (high) 0.101* 0.048 0.118* 0.069
 Self-efficacy (SEMCD-S) − 0.047*** 0.012 − 0.054*** − 0.149
 Pain acceptance (CPAQ) − 0.216*** 0.032 − 0.144*** − 0.147
 Self-efficacy × pain acceptance − 0.021 0.011 − 0.025* − 0.063
 Fibromyalgia 0.309*** 0.048 0.320*** 0.196
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can be changed, it is an asset if the acceptance of the inevi-
table consequences of the disease is part of people’s coping 
repertoire to deal with situations that cannot be changed [20, 
36]. On the other hand, it is also possible that people who 
are able to accept their pain and pursuit their goals actu-
ally receive less invalidation from others. In recent years, 
Acceptance and Commitment Therapy [7] has been applied 
in the treatment of problems that may accompany chronic 
somatic diseases, including several rheumatic diseases [37]. 
This therapy helps people to accept the difficulties that come 
with a chronic disease and to be committed to make changes 
in daily life that are in agreement with one’s life values. 
Toon van Helmond (Sint Maartenskliniek, Nijmegen, the 
Netherlands) proposed a model of dealing with invalida-
tion in which the first steps consist of communication and 
the final step involves acceptance as the best way to deal 
with invalidation when it is difficult to change the environ-
ment [38]: Fig. 3. Ideally, a person has the flexibility to deal 
effectively with invalidation as well as to accept it when the 
situation cannot be changed as was indicated by our finding 
that the combination of high chronic disease self-efficacy 
and high pain acceptance was associated with low lack of 
understanding.
In our study high invalidation, low chronic disease self-
efficacy, and low pain acceptance were more prominent in 
fibromyalgia than in other rheumatic diseases (data analyses 
not shown), which was expected because of the invisibility 
of signs of the disease and its pathological substrate. How-
ever, in all disease groups, using the middle of the response 
scale as cutoff criterion, a minimum of 38% showed low 
pain acceptance, 45% low chronic disease self-efficacy, 23% 
high discounting, and 11% a high lack of understanding. 
This clearly shows that health care professionals should be 
alert to the burden of invalidation in all rheumatic diseases. 
Moreover, our data suggest that it is worth trying to decrease 
invalidation by stimulating chronic disease self-efficacy and 
pain acceptance skills in self-management training, educa-
tional materials, and interventions in patients with rheumatic 
diseases.
Although no causality can be inferred from the cross-sec-
tional design of our study, the results are valuable because 
they give an indication of the prevalence of three aspects 
that are considered core to adjustment to chronic disease 
[5] and because the results indicate who might be better 
protected against invalidation. Future studies with a prospec-
tive or clinical experimental design are needed to clarify 
the causal direction of the observed associations. Further-
more, it would be worthwhile to examine more specifically 
whether patients with a rheumatic disease and high invali-
dation scores can be helped by acquiring skills of accepting 
invalidation (instead of or besides to pain acceptance) and 
by increasing self-efficacy regarding invalidation (instead of 
or besides self-efficacy in dealing with a chronic disease). 
A methodological limitation of the studied sample is that 
inclusion was based on self-reported diagnoses of rheu-
matic diseases without certification by a medical specialist. 
Moreover, the recruitment through the internet may have led 
to a lower representation of the older population and peo-
ple with a low social economic class. Finally, people with 
fibromyalgia were overrepresented in this study. However, 
the findings in the regression analyses remained intact when 
the regressions were adjusted for a fibromyalgia diagnosis 
and demographic characteristics.
The current study shows that invalidation, low chronic 
disease self-efficacy, and low pain acceptance are prominent 
Fig. 2  Invalidation (discounting and lack of understanding) predicted 
by self-efficacy and pain acceptance in 1153 people with rheumatic 
diseases
Fig. 3  Recommendations to deal with invalidation (by Toon van Hel-
mond, Sint Maartenskliniek, Nijmegen, The Netherlands)
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in fibromyalgia and other rheumatic diseases, and that invali-
dation is low in people with higher chronic disease self-effi-
cacy and higher pain acceptance. Additionally, people with 
both higher chronic disease self-efficacy and pain acceptance 
experience the lowest lack of understanding. The findings 
suggest that it is useful to examine whether interventions 
aimed at increasing chronic disease self-efficacy and pain 
acceptance help people with rheumatic diseases for whom 
invalidation is a considerable burden.
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